Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,307.20 -80.41 -0.52%
S&P 500 1,655.35 -13.81 -0.83%
Nasdaq 3,463.30 -38.82 -1.11%
Ticker Volume Price Price Delta
STOXX 50 2,835.01 +13.36 0.47%
FTSE 100 6,840.27 +36.40 0.53%
DAX 8,530.89 +58.69 0.69%
Ticker Volume Price Price Delta
Nikkei 15,627.30 +246.24 1.60%
Hang Seng 23,261.10 -105.29 -0.45%
S&P/ASX 200 5,165.37 -14.69 -0.28%
  • Exchange: NASDAQ GS
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Drugs

ViroPharma Inc

+ Add to Watchlist

VPHM:US

26.1000 USD 0.2400 0.93%

As of 16:00:00 ET on 05/22/2013.

Company Profile for ViroPharma Inc (VPHM)

ViroPharma Incorporated is a biopharmaceutical company committed to the commercialization, development, and discovery of new medicines. The Company's products include a treatment for prophylaxis of hereditary angioedema as well a capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis.

Contact Information

ViroPharma Inc

730 Stockton Drive
Exton, PA 19341-1171
United States
Phone: 1-610-458-7300
Fax: 1-610-458-7380

Key Executives for ViroPharma Inc (VPHM)

Vincent J Milano "Vin"Chairman/President/CEOCharles A Rowland JrVP/CFO
Daniel B SolandVP/COOColin BroomVP/Chief Scientific Officer
Robert G PietruskoVP:RegulatoryJ Peter WolfVP/Secretary/Gen Cnsl

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil